Literature DB >> 18682521

Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders.

S Møller-Larsen1, M Nyegaard, A Haagerup, J Vestbo, T A Kruse, A D Børglum.   

Abstract

BACKGROUND: Toll-like receptors (TLRs) are structurally and functionally related and play important roles in the innate and adaptive immune system. By genome scanning, evidence of linkage between chromosome Xp22 and asthma and related atopic disorders has previously been obtained. Xp22 harbours the TLR7 and TLR8 genes.
METHODS: The involvement of TLR7 and TLR8 in the aetiology of asthma and related disorders was investigated by a family based association analysis of two independently ascertained family samples comprising 540 and 424 individuals from 135 and 100 families, respectively. Ten affected individuals from families showing evidence of linkage to Xp22 were screened for sequence variations in TLR7 and 8, and nine single nucleotide polymorphisms (SNPs) identified were tested for association.
RESULTS: In both samples, significant associations were observed for single SNPs and haplotypes of both TLR7 and 8 in all four phenotypes investigated: asthma, rhinitis, atopic dermatitis and increased specific IgE. The most significant association was seen for rs2407992 (TLR8) in asthma (p = 0.00023, sample A and B combined, recessive model). In TLR7, rs179008 showed the strongest association. Both rs179008 and rs2407992 are of putative functional significance, potentially affecting TLR7 processing and TLR8 splicing, respectively. Haplotypes comprising the major alleles of these two SNPs were overtransmitted to the affected offspring (eg, p = 0.00012 in asthma, combined sample, additive model).
CONCLUSION: The results provide strong evidence that TLR7 and 8 may confer susceptibility to asthma and related atopic disorders and highlight these receptors as interesting targets for individualised, causally directed treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682521     DOI: 10.1136/thx.2007.094128

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  58 in total

1.  The -159C/T polymorphism in the CD14 gene and the risk of asthma: a meta-analysis.

Authors:  Yonggang Zhang; Can Tian; Jie Zhang; Xiaobo Li; Hua Wan; Chao He; Liang Guo; Quocuo Meilang; Chunhong Peng; Lina Duo; Jin Huang; Hong Fan
Journal:  Immunogenetics       Date:  2010-11-16       Impact factor: 2.846

2.  Functional polymorphisms of TLR8 are associated with hepatitis C virus infection.

Authors:  Chiou-Huey Wang; Hock-Liew Eng; Kuei-Hsiang Lin; Hsiang-Chun Liu; Cheng-Hsien Chang; Tsun-Mei Lin
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

3.  Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma.

Authors:  Rachel Lubong Sabado; Anna Pavlick; Sacha Gnjatic; Crystal M Cruz; Isabelita Vengco; Farah Hasan; Meredith Spadaccia; Farbod Darvishian; Luis Chiriboga; Rose Marie Holman; Juliet Escalon; Caroline Muren; Crystal Escano; Ethel Yepes; Dunbar Sharpe; John P Vasilakos; Linda Rolnitzsky; Judith Goldberg; John Mandeli; Sylvia Adams; Achim Jungbluth; Linda Pan; Ralph Venhaus; Patrick A Ott; Nina Bhardwaj
Journal:  Cancer Immunol Res       Date:  2015-01-29       Impact factor: 11.151

4.  Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation.

Authors:  Nicholas W Lukacs; Joost J Smit; Sumanta Mukherjee; Susan B Morris; Gabriel Nunez; Dennis M Lindell
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

5.  Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease.

Authors:  Teresa Requena; Irene Gazquez; Antonia Moreno; Angel Batuecas; Ismael Aran; Andres Soto-Varela; Sofia Santos-Perez; Nicolas Perez; Herminio Perez-Garrigues; Alicia Lopez-Nevot; Eduardo Martin; Ricardo Sanz; Paz Perez; Gabriel Trinidad; Marta E Alarcon-Riquelme; Roberto Teggi; Laura Zagato; Miguel A Lopez-Nevot; Jose A Lopez-Escamez
Journal:  Immunogenetics       Date:  2013-02-01       Impact factor: 2.846

6.  Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine.

Authors:  Holly D Clifford; Stephanie T Yerkovich; Siew-Kim Khoo; Guicheng Zhang; John Upham; Peter N Le Souëf; Peter Richmond; Catherine M Hayden
Journal:  Immunogenetics       Date:  2011-09-23       Impact factor: 2.846

7.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

Review 8.  The therapeutic potential of Toll-like receptor 7 stimulation in asthma.

Authors:  Matthew G Drake; Elad H Kaufman; Allison D Fryer; David B Jacoby
Journal:  Inflamm Allergy Drug Targets       Date:  2012-12

Review 9.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

10.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Authors:  Timothy M Bahr; Grant J Hughes; Michael Armstrong; Rick Reisdorph; Christopher D Coldren; Michael G Edwards; Christina Schnell; Ross Kedl; Daniel J LaFlamme; Nichole Reisdorph; Katerina J Kechris; Russell P Bowler
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.